Lazaro E, San Felix A, van den Broek L A, Ottenheijm H C, Ballesta J P
Centro de Biología Molecular, Universidad Autónoma, Madrid, Spain.
Antimicrob Agents Chemother. 1991 Jan;35(1):10-3. doi: 10.1128/AAC.35.1.10.
Phenol-alanine-sparsomycin, a derivative of sparsomycin carrying a p-hydroxy-benzyl function easily labeled by iodination, has been used to study the interaction of this drug with the ribosome. Our study indicated that the binding of the drug to the ribosome is sensitive to trichloracetic acid and is equally affected by disintegration of the particle after RNase and protease treatments. The ribosome is not irreversibly inactivated, and the chemical structure of the drug is not affected by interaction with the particle. These data are not compatible with the proposed covalent association of sparsomycin with the ribosome by G. A. Flynn and R. J. Ash (Biochem. Biophys. Res. Commun. 114:1-7, 1983); therefore, the antibiotic must inhibit protein synthesis through a reversible interaction with the ribosome.
苯酚 - 丙氨酸 - 稀疏霉素是稀疏霉素的一种衍生物,带有一个易于通过碘化标记的对羟基苄基官能团,已被用于研究该药物与核糖体的相互作用。我们的研究表明,药物与核糖体的结合对三氯乙酸敏感,并且在核糖核酸酶和蛋白酶处理后颗粒解体时受到同等影响。核糖体不会被不可逆地灭活,并且药物的化学结构不会因与颗粒的相互作用而受到影响。这些数据与G. A. 弗林和R. J. 阿什提出的稀疏霉素与核糖体的共价结合(《生物化学与生物物理研究通讯》114:1 - 7, 1983)不相符;因此,该抗生素必须通过与核糖体的可逆相互作用来抑制蛋白质合成。